Evaluating a Wireless NIRS Device in the Neonatal Intensive Care Unit

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorMcGill University Health Centre/Research Institute of the McGill University Health Centre

About this trial

The wireless NIRS sensor will be placed on the participant's forehead, directly underneath the INVOS wired sensor. The wireless NIRS sensor will remain in place for 4 consecutive hours, over 2 consecutive days. As standard-of-care, nursing personnel removes all sensors at every care to evaluate skin and reduce the risk of pressure sores. The wireless NIRS device will be removed and reapplied at the same time, by the research team who will annotate what time the sensor was removed, replaced, and the condition of the skin. This will be used to correlate signal disconnection with sensor care (i.e., skin checks, sensor removal, etc.).

Eligibility criteria

Qualifiers

Infants admitted to the NICU with a gestational age of ≥ 32 weeks at the time of the monitoring

undergoing monitoring with the INVOS wired NIRS system.

Disqualifiers

Infants with a skin abnormality that would potentially increase the risk of injury,

Patient too unstable or family experiencing too much stress as determined by an attending physician or bedside care team to not be approached for recruitment.

Trial design

Treatments tested in this trial

  • Wireless NIRS

Treatment groups

20 Participants
are divided into 1 treatment group